$2.17
+0.0000%Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
Chief Commercial Officer
Chief Financial Officer
Compensation
$480,925
Co-Founder, Chief Executive Officer, President & Executive Chairman of the Board
Compensation
$75,000
Co-Founder, Chief Strategy Officer & Director
Compensation
$113,699
Executive Vice President, General Counsel & Secretary
Compensation
$416,316
President of Kyber Data Science
Vice President of Corporate Development
During the last 12 months, insiders have purchased $1.49M and sold $7K worth of FORA shares, resulting in $1.49M of net buying activity.
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
150.0K
336.00K
0
0.00
+336K
+$336K
600.0K
1.16M
3.3K
6.96K
+1.2M
+$1.15M
Vesey Michael
Officer: Chief Financial Officer
$386K
Wygod Max C
Director, 10 Percent Owner, Officer: Exec Chairman, Ceo & President
$386K
Dublin Adam H
Director, Officer: Chief Strategy Officer
$386K
Mcgrail Caroline Strickland
Officer: General Counsel
$336K
Vesey Michael
Officer: Chief Financial Officer
$7K
Strong bullish signal with $1.49M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
4 insider buyers vs. 1 sellers. Broad-based buying across management team suggests widespread confidence.
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
FORA - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | December 15, 2025 | January 08, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 29, 2025 | June 11, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 29, 2024 | June 12, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 28, 2023 | June 14, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 28, 2022 | June 15, 2022 | 2022 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.